We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: CP25712
CAS No: 288617-73-2
Synonyms/Alias: 288617-73-2;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid;(S)-N-FMoc-2-(4'-pentenyl)alanine;(S)-N-Fmoc-|A-(4-Pentenyl)Alanine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylhept-6-enoic acid;6-Heptenoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-, (2S)-;Fmoc-(S)-2-(4-pentenyl)Ala-OH;(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-6-heptenoic acid;(S)-2-(Fmoc-amino)-2-methyl-6-heptenoic Acid;MFCD09879888;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-hept-6-enoic acid;Fmoc-(Me)Gly(Pentenyl)-OH;Fmoc-S5-OH;(S)-N-Fmoc-alpha-(4-Pentenyl)Alanine;(S)-FMoc-alpha-Me-Gly(Pentenyl)-OH;(S)-N-Fmoc-alpha-(4-Pentenyl)Alanine;(S)-N-(9-Fluorenylmethylcarbamate)-2-(2'-pentenyl)alanine;(S)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-2-METHYLHEPT-6-ENOIC ACID;SCHEMBL574713;DTXSID30670477;BCP06609;EX-A3852;MFCD09879889;AKOS015918396;(S)-N-Fmoc-beta-(4-pentenyl)alanine;CS-W004864;AC-27572;DS-17841;DB-027152;F12100;(S)-N-Fmoc-a(1/4) feminine-(4-Pentenyl)Alanine;S-288617-73-2;(2S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-methylhept-6-enoic acid;(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-2-METHYLHEPT-6-ENOIC ACID;Fmoc-S5-OH;(S)-N-Fmoc--(4-Pentenyl)Alanine;(S)-FMoc--Me-Gly(Pentenyl)-OH;(2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-6-heptenoic acid (Fmoc-D-aMeNva(Vinyl)-OH);
Chemical Name: (S)-2-(9-Fluorenylmethyloxycarbonyl)amino-2-methylhept-6-enoic acid (contains 20 to 50% MTBE)
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C23H25NO4 |
M.W/Mr. | 379.4 |
Sequence | Three Letter Code:Fmoc-aMeNva(vinyl)(vinyl)-OH |
Application | Peptide synthesis; Drug screening |
Purity | 0.98 |
Size | 1 g;5 g; |
InChI | InChI=1S/C23H25NO4/c1-3-4-9-14-23(2,21(25)26)24-22(27)28-15-20-18-12-7-5-10-16(18)17-11-6-8-13-19(17)20/h3,5-8,10-13,20H,1,4,9,14-15H2,2H3,(H,24,27)(H,25,26)/t23-/m0/s1 |
InChI Key | MRJFPZWLOJOINV-QHCPKHFHSA-N |
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com